Monday, June 15, 2026

#FDA

3 articles

ADC Combination Trials Converge on 2026–2027 Regulatory Window, Concentrating Biotech Binary Risk

Biotech Investment

ADC Combination Trials Converge on 2026–2027 Regulatory Window, Concentrating Biotech Binary Risk

Salvado•May 27, 2026

Paradigm Health Goes Live With Amgen and AstraZeneca Trials Simultaneously, Exposing Partners to Catastrophic Data Risk

Risk Management

Paradigm Health Goes Live With Amgen and AstraZeneca Trials Simultaneously, Exposing Partners to Catastrophic Data Risk

Salvado•May 1, 2026

Major Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA Approvals

Major Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA Approvals

ViaNews Editorial Team (Finance)•Feb 15, 2026